Back to companies

KPC Pharmaceuticals Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

KPC Pharmaceuticals Inc (KPC) is a pharmaceutical company that specializes in the development and production of natural medicine products. The company's main activities include drug research and development, production, sales, commercial wholesale, and international marketing. It offers products such as three series of Artemisia annua, Panax notoginseng, and Gastrodia elata, along with over forty new natural medicine products. The company serves its products under the brands Tianxuanqing, Luotai, Artemedine, Arco, and Artem. KPC’s drugs are used for the treatment of central nervous system disorders, cardiovascular, cardio-cerebral-vascular, chronic disease, disorders, and malaria. It has operations across Asia, Europe, Africa, Oceania, and South America. KPC is headquartered in Kunming, Yunnan, China.

Gain a 360-degree view of KPC Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of KPC Pharmaceuticals Inc and make more informed decisions for your business Register your interest
Headquarters China

Address High-tech Development Zone, No. 166, Keyi Road, Kunming, Yunnan, 650106


Telephone 86 871 68319868

No of Employees 5,072

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 600422 (SHA)

Revenue (2024) $914.9M -21.7% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ -46% (2024 vs 2023)

Market Cap* $907.7M

Net Profit Margin (2024) XYZ -31.0% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

KPC Pharmaceuticals Inc premium industry data and analytics

20+

Clinical Trials

Determine KPC Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Marketed Drugs

Understand KPC Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

12+

Catalyst Calendar

Proactively evaluate KPC Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

3

Pipeline Drugs

Identify which of KPC Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Artemether Artem
Gastrodia Elata Arco
Panax Notoginseng Luotai
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand KPC Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand KPC Pharmaceuticals Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters KPC Pharmaceuticals Inc Jointown Pharmaceutical Group Co Ltd Shenzhen Neptunus Bioengineering Co Ltd Jiangsu Nhwa Pharmaceutical Co Ltd Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
Headquarters China China China China China
City Kunming Wuhan Shenzhen Xuzhou Hangzhou
State/Province Yunnan Hubei Guangdong Jiangsu Zhejiang
No. of Employees 5,072 29,862 6,734 6,003 392
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Wu Wenduo Chairman Executive Board 2025 53
Yan Wei President; Vice Chairman Executive Board 2023 55
Li Hongshen Vice Chairman Executive Board 2024 48
Gao Tong Vice President Senior Management 2024 46
Liu Junfeng Senior Vice President Senior Management 2017 50
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into KPC Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into KPC Pharmaceuticals Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?